期刊文献+

氟尿嘧啶加甲酰四氢叶酸术前化疗对人体胃癌细胞凋亡与增殖的影响 被引量:2

Influence of preoperative chemotherapy with 5-fluoro-uracilum and citrovorum factor on apoptosis and proliferation of human gastric carcinoma cells
原文传递
导出
摘要 目的探讨氟尿嘧啶加甲酰四氢叶酸(5-FU加CF)术前化疗对人体胃癌细胞凋亡与增殖的影响。方法分别应用原位末端标记法(TUNEL)及免疫组织化学LSAB法,对35例胃癌患者经5-FU加CF术前化疗前后的肿瘤组织进行细胞凋亡指数(AI)及增殖细胞核抗原(PCNA)检测。结果5-FU加CF化疗后人体胃癌组织细胞AI为(6.245±2.127)%,明显高于化疗前(4.340±1.570)%(t=7.585,P<0.001)。PCNA表达化疗后为(42.21±8.01)%,明显低于化疗前(58.52±14.76)%(t=7.870,P<0.001)。结论在人体胃癌组织中,5-FU加CF术前化疗可诱导肿瘤细胞发生凋亡,并抑制其增殖。 Objective To investigate the influence of preoperative chemotherapy with 5 flumoro uracilum(5 FU) and citrovorum factor(CF) on apoptosis and proliferation of human gastric carcinoma cells. Methods Tissue samples of 35 patients with resectable gastric carcinoma before and after the preoperative chemotherapy with 5 FU and CF were processed to test apoptotic indices (AI) and PCNA expression using TdT mediated dUTP nick end labeling(TUNEL) and immunohistochemical stainning. Results AI of tumor tissue after the preoperative chemotherapy was significantly higher than that before the chemotherapy. PCNA expression in human gastric carcinoma decreased significantly after the preoperative chemotherapy (P< 0 01). Conclusion Preoperative chemotherapy with 5 FU and CF can induce apoptosis and inhibit proliferation of human gastric carcinoma.
出处 《中华胃肠外科杂志》 CAS 2003年第1期47-49,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 胃肿瘤 化疗 凋亡 增殖 Stomach neoplasms Chemotherapy Apoptosis Proliferation
  • 相关文献

参考文献2

  • 1U. Fink M.D.,H. J. Stein M.D.,C. Schuhmacher M.D.,H. J. Wilke M.D.. Neoadjuvant chemotherapy for gastric cancer: Update[J] 1995,World Journal of Surgery(4):509~516
  • 2H. Wilke M.D.,M. Stahl M.D.,U. Fink M.D.,H-J. Meyer M.D.,J. R. Siewert M.D.. Preoperative chemotherapy for unresectable gastric cancer[J] 1995,World Journal of Surgery(2):210~215

同被引文献21

  • 1Ajani A, Yao JC. Preoperative therapy for local regional gastric cancer: rational eandreviewoftrials. GanToKagakuRyoho, 2000,27 (Supp 12): 392~394.
  • 2Schuhmacher C, Fink U, Siewert JR. Preoperative downstaging in advanced stomach carcinoma. Wishfulthinkingorreality.ZentralblChir, 2000, 125 (4): 330~340.
  • 3Kollmannsberger C, Quietzsch D, Hang C, et al. Aphase Ⅱ study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil,folinicacid and cisplatin inpatients with advanced gastric cancer. Br J Cancer, 2000, 83 (4): 458~462.
  • 4Cascinu S, Graziano F, Barbi S, et al. Aphase Ⅱ study of sequential chemotherapy with docetaxel after the weekly PELF egimenin advanced gastric cancer: A reportomther Italian group for the study of digestive tract cancer. Br J Cancer, 2001, 84(4): 470~474.
  • 5Shimoyama S, Shimizu N, Kaminishi M. Type-oriented intraoperatived intraoperative and adjuvant chemotherapy and survival after curative resection of advancedgastric cancer. World J surg,1999, 23 (3): 284~292.
  • 6Kim YH, Shin SW, Kim BS, et al. Paclitaxel, 5 fluorouracil and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer, 1999, 85: 295.
  • 7Obtsu A, Sbirao K, Miyata Y, et al. Aphase Ⅱ study of three hour infusion paclitaxel inpatients with advanced gastric cancer.Proceeding of ASCO, 2000, 19: 303a.
  • 8Kollmaonsberger C, Quietzch D, Haag C, et al. Aphase Ⅱ study of paclitaxel weekly 24 hour continuous infusion 5Fu, folinicacid and cisplantin inpatients with advanced gastric cancer. Proceeding of ASCO, 2000, 19: 265a.
  • 9Rosen H. Stomach carcinoma optimizing therapy by neoadjuvant or adjuvant therapy. Zentralbl Chir, 1999, 124 (5): 387~393.
  • 10Yu W, Whang I, Averbach A, et al. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gas-triccancer. Am Surg, 1998,64(11): 1104~1108.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部